EUVIMEDEUVIMED entdecken
Crossref

Click‐Chemistry‐Mediated Cell Membrane Glycopolymer Engineering to Potentiate Dendritic Cell Vaccines

He Yang iD, Zijian Xiong, Xingyu Heng, Xiaomeng Niu, Yichen Wang, Lihua Yao, Lele Sun iD, Zhuang Liu iD, Hong Chen iD

Angewandte Chemie International Edition · 2024

DOI: 10.1002/anie.202315782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von He Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, Jiangsu, China. Hauptthemen laut MEDLINE: Neoplasms, Vaccines. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cell vaccine (DCV) holds great potential in tumor immunotherapy owing to its potent ability in eliciting tumor‐specific immune responses. Aiming at engineering enhanced DCV, we report the first effort to construct a glycopolymer‐engineered DC vaccine (G‐DCV) via metabolicglycoengineering and copper‐free click‐chemistry. Model G‐DCV was prepared by firstly delivering tumor antigens, ovalbumin (OVA) into dendritic cells (DC) with fluoroalkane‐grafted polyethyleneimines, followed by conjugating glycopolymers with a terminal group of dibenzocyclooctyne (DBCO) onto dendritic cells. Compared to unmodified DCV, our G‐DCV could induce stronger T cell activation due to the enhanced adhesion between DCs and T cells. Notably, such G‐DCV could more effectively inhibit the growth of the mouse B16‐OVA (expressing OVA antigen) tumor model after adoptive transfer. Moreover, by combination with an immune checkpoint inhibitor, G‐DCV showed further increased anti‐tumor effects in treating different tumor models. Thus, our work provides a novel strategy to enhance the therapeutic effectiveness of DC vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsVaccinesMiceAnimalsT-LymphocytesAntigens, NeoplasmOvalbuminCell MembraneDendritic Cells

Stichwörter der Autor:innen

Cell Surface ModificationDendritic Cell VaccinesPolymerT-Cell ActivationTumor Immunotherapy

Substanzen

Antigens, NeoplasmOvalbuminVaccines

Autor:innen und Institutionen

  • College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, Jiangsu, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Lab Carbon Based Functional Materials and Devices, Soochow University, Suzhou, 215123, Jiangsu, China.
  • Institute of Materiobiology, Department of Chemistry, College of Science, Shanghai University, Shanghai, 200444, China.

ORCID-Profile: He Yang, Lele Sun, Zhuang Liu, Hong Chen

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Yang, H., Xiong, Z., Heng, X., Niu, X., Wang, Y., Yao, L., Sun, L., Liu, Z., & Chen, H. (2024). Click‐Chemistry‐Mediated Cell Membrane Glycopolymer Engineering to Potentiate Dendritic Cell Vaccines. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202315782

Vancouver

Yang H, Xiong Z, Heng X, Niu X, Wang Y, Yao L, et al. Click‐Chemistry‐Mediated Cell Membrane Glycopolymer Engineering to Potentiate Dendritic Cell Vaccines. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202315782

BibTeX
@article{Yang2024,
  author = {Yang, He and Xiong, Zijian and Heng, Xingyu and Niu, Xiaomeng and Wang, Yichen and Yao, Lihua and Sun, Lele and Liu, Zhuang and Chen, Hong},
  title = {Click‐Chemistry‐Mediated Cell Membrane Glycopolymer Engineering to Potentiate Dendritic Cell Vaccines},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  doi = {10.1002/anie.202315782}
}
Kostenlos starten →